In this issue of Blood, Hechinger and colleagues investigate the efficacy of the blockade of the common γ-chain receptor (CD132) as a novel approach in the management of both acute and chronic graft-versus-host disease (GVHD).
CITATION STYLE
Pérez-Simón, J. A. (2015, January 15). Anti-common γ-chain antibody: One for all in GVHD. Blood. American Society of Hematology. https://doi.org/10.1182/blood-2014-12-610659
Mendeley helps you to discover research relevant for your work.